arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Surgery Partners, Inc.

SGRY
$23.19 ▲ +0.03 (+0.13%) at close
Healthcare ·Services-General Medical & Surgical Hospitals, NEC ·USServices-General Medical & Surgical Hospitals, NEC
47 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
35
Health
Weak
Bearish
auto_awesome

Analytical Summary

Surgery Partners, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $3.0B
Dividend Yield —
Revenue Growth 2.7% ↘
Op. Margin 12.0% ↗
ROIC 4.8% ↗
FCF / Share $0.29 ↗
Trailing P/E —
Price / Book 1.8x
FCF Yield 1.3%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

47-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$848.90M
↑ +2.7% —
Net Income Profit after all expenses
$-15.00M
↓ -500.0% —
Operating Margin Operating profit as % of sales
12.0%
↑ +48.2% 60th
FCF / Share Free cash flow per share
$0.29
↑ +969.0% —
Long-Term Debt Long-term obligations
$3.74B
↑ +33.2% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↑
45
Returns ↑
39
Financial Health ↓
34
Cash Quality ↓
6

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 13 years · 47 quarters